This Hedge Fund Just Exited XPeng: Should You Do the Same?
A prominent hedge fund just sold its entire XPeng stake, triggering questions for everyday investors. Learn how to ev...
Explore the core reasons index funds tend to outperform active funds over the long run, focusing on fee drag, turnover impact, and diversification.
22,990 articlesA prominent hedge fund just sold its entire XPeng stake, triggering questions for everyday investors. Learn how to ev...
A wall street analyst thinks Viking Therapeutics could unlock substantial upside if VK2735 delivers in Phase 3. Learn...
Micron’s stock has surged dramatically in the last year. While some analysts see meaningful upside from current level...
As data centers expand and AI workloads surge, the tech industry faces a critical power reliability challenge. This a...
When big-name releases head to vinyl, your wallet feels the impact. This guide breaks down budgeting, costs, and prac...
NuScale Power's stock action sparks questions about small modular reactors and policy timelines. This guide breaks do...
A notable stake by 140 Summer Partners LP in Acuity Brands is turning heads in the investing world. This article brea...
A biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
Cathie Wood’s approach to downturns leans into disciplined bargain hunting. This article breaks down the idea of cath...
Gossamer Bio's 2026 earnings outlook centers on cash runway, pipeline progress, and strategic partnerships. This arti...
If you’re chasing steady income, the default move isn’t always the highest yield. This guide explains why a dividend ...
As markets navigated a cautious session, Sunrun’s new framework with Tesla and Renew Home pushed renewable energy equ...